| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.318 | 7.932 | 8.835 | 10.945 | 12.293 | 9.701 | 6.765 | 132 | 0 | - |
| Total Income - EUR | 7.335 | 7.937 | 8.835 | 10.945 | 12.293 | 9.701 | 6.789 | 132 | 0 | - |
| Total Expenses - EUR | 2.013 | 1.592 | 2.919 | 1.758 | 1.843 | 1.197 | 1.217 | 231 | 0 | - |
| Gross Profit/Loss - EUR | 5.322 | 6.345 | 5.916 | 9.187 | 10.450 | 8.504 | 5.572 | -100 | 0 | - |
| Net Profit/Loss - EUR | 5.102 | 6.106 | 5.651 | 8.859 | 10.081 | 8.227 | 5.373 | -104 | 0 | - |
| Employees | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | - |
Check the financial reports for the company - Egi - Medica International S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 5.334 | 6.346 | 5.893 | 9.099 | 10.321 | 8.416 | 5.521 | 2 | 2 | - |
| Inventories | 1.292 | 1.279 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 528 | 545 | 332 | 653 | 508 | 544 | 0 | 2 | 2 | - |
| Cash | 3.514 | 4.522 | 5.561 | 8.445 | 9.813 | 7.872 | 5.521 | 0 | 0 | - |
| Shareholders Funds | 5.160 | 6.163 | 5.707 | 8.914 | 10.135 | 8.280 | 5.424 | -52 | -52 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 175 | 182 | 185 | 184 | 186 | 136 | 96 | 54 | 54 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Egi - Medica International S.r.l.